查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1370340

聚合酶炼式反应市场：2023-2028 年全球产业趋势、份额、规模、成长、机会与预测

Polymerase Chain Reaction Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2023-2028 年市场概况：

2022年全球聚合酶连锁反应市场规模达71亿美元。展望未来，IMARC集团预计到2028年市场规模将达到109亿美元，2023-2028年复合年增长率（CAGR）为7.3%。

聚合酶炼式反应 (PCR) 是一种分子诊断技术，用于製备 DNA 片段的多个副本。 PCR 机用于在自动和预编程程序中控製样品的温度，以准确产生数百万个 DNA 定序副本。此技术可识别和培养致病微生物，有助于检测结核病、后天免疫缺乏症候群（爱滋病）、感染和莱姆病。因此，它在各种生命科学相关领域中广泛应用，例如遗传学、生物技术、分子生物学、药物发现和临床诊断。

全球聚合酶炼式反应市场趋势与驱动因素：

各种传染病和遗传性疾病的日益普及是推动市场成长的关键因素之一。全球老年人口不断增加，更容易罹患慢性病，也推动了该产业的成长。冠状病毒病（COVID-19）大流行的爆发进一步导致PCR技术的广泛采用，以准确诊断和早期检测感染。 PCR 设备还有助于最大限度地减少整个过程中的污染风险和人为错误的可能性。

对个人化和精准医疗的需求不断增长也为市场创造了积极的前景。这些药物旨在提供量身定制的疗法，这些疗法是使用 PCR 技术识别和开发的。其他因素，包括临床诊断应用的增加，以及生物技术领域的广泛研发（R&D）活动，预计将进一步推动市场发展。

本报告回答的关键问题：

  • 迄今为止，全球聚合酶炼式反应市场表现如何，未来几年又会如何表现？
  • COVID-19 对全球聚合酶炼式反应市场有何影响？
  • 主要区域市场有哪些？
  • 基于产品的市场区隔是什么？
  • 基于最终用户的市场区隔是什么？
  • 产业价值链的各个阶段是什么？
  • 该行业的关键驱动因素和挑战是什么？
  • 全球聚合酶炼式反应市场的结构如何？谁是主要参与者？
  • 产业竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球聚合酶炼式反应市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：按产品分類的市场区隔

  • 仪器
    • 市场走向
    • 按类型分類的市场细分
      • 标准 PCR 系统
        • 市场走向
        • 市场预测
      • 数位 PCR 系统
        • 市场走向
        • 市场预测
      • 实时萤光定量PCR系统
        • 市场走向
        • 市场预测
    • 市场预测
  • 试剂及耗材
    • 市场走向
    • 市场预测
  • 软体和服务
    • 市场走向
    • 市场预测

第 7 章：最终用户的市场区隔

  • 学术及研究机构
    • 市场走向
    • 市场预测
  • 临床诊断实验室和医院
    • 市场走向
    • 市场预测
  • 製药和生物技术公司
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太地区
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 9 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章：价值链分析

第 11 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章：价格分析

第13章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • BD (Becton, Dickinson and Company)
    • BioMerieux (Institut Merieux SA)
    • Bio-RAD Laboratories Inc.
    • F. Hoffmann-La Roche AG
    • Fluidigm Corporation
    • Merck KGaA
    • Perkinelmer Inc.
    • Promega Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
Product Code: SR112023A2315

Abstract

Market Overview 2023-2028:

The global polymerase chain reaction market size reached US$ 7.1 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 10.9 Billion by 2028, exhibiting a growth rate (CAGR) of 7.3% during 2023-2028.

Polymerase chain reaction (PCR) refers to a molecular diagnostic technique that is used to make multiple copies of a segment of DNA. A PCR machine is used to manipulate the temperature of the sample in an automatic and pre-programmed procedure to generate millions of copies of DNA sequencing accurately. This technology identifies and cultures disease-causing microorganisms, which aid in the detection of tuberculosis, Acquired Immunodeficiency Syndrome (AIDS), infections and Lyme disease. Owing to this, it finds extensive applications across various life science-related fields, such as genetics, biotechnology, molecular biology, drug discovery and clinical diagnostics.

Global Polymerase Chain Reaction Market Trends and Drivers:

The increasing prevalence of various infectious diseases and genetic disorders is one of the key factors driving the growth of the market. The rising geriatric population across the globe, which is more prone to chronic medical ailments, is also driving the industry growth. The outbreak of the coronavirus disease (COVID-19) pandemic has further led to the widespread adoption of PCR technologies for accurate diagnosis and early detection of infections. PCR devices also aid in minimizing the risks of contamination and the chances of human errors in the entire process.

The increasing demand for personalized and precision medicines is also creating a positive outlook for the market. These medicines aim to provide tailor-made therapies, which are identified and developed using PCR technologies. Other factors, including the increasing application in clinical diagnostics, along with extensive research and development (R&D) activities in the field of biotechnology, are expected to drive the market further.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global polymerase chain reaction market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product and end user.

Breakup by Product:

Instruments

Standard PCR Systems

Digital PCR Systems

Real-time PCR Systems

Reagents and Consumables

Software and Services

Breakup by End User:

Academic and Research Institutes

Clinical Diagnostics Labs and Hospitals

Pharmaceutical and Biotechnology Companies

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Agilent Technologies Inc., BD (Becton, Dickinson and Company), BioMerieux (Institut Merieux SA), Bio-RAD Laboratories Inc., F. Hoffmann-La Roche AG, Fluidigm Corporation, Merck KGaA, Perkinelmer Inc., Promega Corporation, Takara Bio Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global polymerase chain reaction market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global polymerase chain reaction market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global polymerase chain reaction market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Polymerase Chain Reaction Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Breakup by Type
      • 6.1.2.1 Standard PCR Systems
        • 6.1.2.1.1 Market Trends
        • 6.1.2.1.2 Market Forecast
      • 6.1.2.2 Digital PCR Systems
        • 6.1.2.2.1 Market Trends
        • 6.1.2.2.2 Market Forecast
      • 6.1.2.3 Real-Time PCR Systems
        • 6.1.2.3.1 Market Trends
        • 6.1.2.3.2 Market Forecast
    • 6.1.3 Market Forecast
  • 6.2 Reagents and Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by End User

  • 7.1 Academic and Research Institutes
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Clinical Diagnostics Labs and Hospitals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Pharmaceutical and Biotechnology Companies
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 BD (Becton, Dickinson and Company)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 Financials
      • 13.3.2.4 SWOT Analysis
    • 13.3.3 BioMerieux (Institut Merieux SA)
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 Bio-RAD Laboratories Inc.
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 F. Hoffmann-La Roche AG
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
    • 13.3.6 Fluidigm Corporation
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
    • 13.3.7 Merck KGaA
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Perkinelmer Inc.
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Promega Corporation
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
    • 13.3.10 Takara Bio Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
    • 13.3.11 Thermo Fisher Scientific Inc.
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
      • 13.3.11.3 Financials
      • 13.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Polymerase Chain Reaction Market: Major Drivers and Challenges
  • Figure 2: Global: Polymerase Chain Reaction Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Polymerase Chain Reaction Market: Breakup by Product (in %), 2022
  • Figure 4: Global: Polymerase Chain Reaction Market: Breakup by End User (in %), 2022
  • Figure 5: Global: Polymerase Chain Reaction Market: Breakup by Region (in %), 2022
  • Figure 6: Global: Polymerase Chain Reaction Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 7: Global: Polymerase Chain Reaction (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 8: Global: Polymerase Chain Reaction (Instruments) Market: Breakup by Type (in %), 2022
  • Figure 9: Global: Polymerase Chain Reaction (Instruments- Standard PCR Systems) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Polymerase Chain Reaction (Instruments- Standard PCR Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Polymerase Chain Reaction (Instruments- Digital PCR Systems) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Polymerase Chain Reaction (Instruments- Digital PCR Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Polymerase Chain Reaction (Instruments- Real-Time PCR Systems) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Polymerase Chain Reaction (Instruments- Real-Time PCR Systems) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Polymerase Chain Reaction (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Polymerase Chain Reaction (Reagents and Consumables) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Polymerase Chain Reaction (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Polymerase Chain Reaction (Software and Services) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Polymerase Chain Reaction (Software and Services) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Polymerase Chain Reaction (Academic and Research Institutes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Polymerase Chain Reaction (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Polymerase Chain Reaction (Clinical Diagnostics Labs and Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Polymerase Chain Reaction (Clinical Diagnostics Labs and Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Polymerase Chain Reaction (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Polymerase Chain Reaction (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Polymerase Chain Reaction (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Polymerase Chain Reaction (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: North America: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: North America: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: United States: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: United States: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Canada: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Canada: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Asia Pacific: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Asia Pacific: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: China: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: China: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Japan: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Japan: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: India: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: India: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: South Korea: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: South Korea: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Australia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Australia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Indonesia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Indonesia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Europe: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Europe: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Germany: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Germany: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: France: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: France: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: United Kingdom: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: United Kingdom: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Italy: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Italy: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Spain: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Spain: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Russia: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Russia: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Latin America: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Latin America: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Brazil: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Brazil: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Mexico: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Mexico: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Middle East and Africa: Polymerase Chain Reaction Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Middle East and Africa: Polymerase Chain Reaction Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Global: Polymerase Chain Reaction Industry: SWOT Analysis
  • Figure 77: Global: Polymerase Chain Reaction Industry: Value Chain Analysis
  • Figure 78: Global: Polymerase Chain Reaction Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Polymerase Chain Reaction Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Polymerase Chain Reaction Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Polymerase Chain Reaction Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 4: Global: Polymerase Chain Reaction Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 5: Global: Polymerase Chain Reaction Market Structure
  • Table 6: Global: Polymerase Chain Reaction Market: Key Players